Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40 results about "Extracellular matrix scaffold" patented technology

Biological scaffolds derived from extracellular matrix (ECM) have been widely utilised in regenerative medicine. The ECM is an essential non-cellular component of the tissue microenvironment, comprised of a network of macromolecules including polysaccharide glycosaminoglycans (GAGs) and proteins such as collagens, laminins, and fibronectin.

Nucleus pulposus-cartilage extracellular matrix scaffold and preparing method thereof

InactiveCN105031734AOvercome the disadvantages of small quantities and difficult accessGood biocompatibilityProsthesisArticular surfacesArticular surface
The invention discloses a nucleus pulposus-cartilage extracellular matrix scaffold and a preparing method thereof and belongs to the biological tissue engineering technology. The preparing method comprises the steps that nucleus pulposuses and bony articular surface cartilage are smashed, decellularized, subjected to gradient centrifugation to collect extracellular matrix microfilament suspension, and freeze-dried to obtain a freeze-dried decellularized nucleus pulposus matrix and a freeze-dried decellularized cartilage matrix, the two matrixes are taken in certain proportion and dissolved in ultrapure water to prepare mixed matrix suspension with certain concentration, and the mixed matrix suspension is freeze-dried and subjected to ultraviolet irradiation crosslinking and chemical reagent crosslinking in sequence so that the nucleus pulposus-cartilage extracellular matrix scaffold can be obtained. In this way, the defect that the nucleus pulposuses are hard to obtain due to the small number is overcome; the preparing technology is simple, and decellularizing can be achieved thoroughly; the matrix scaffold is degradable and high in biocompatibility; the matrix scaffold is of a three-dimensional structure, is high in mechanical property and plasticity, and can facilitate the distribution, growth and differentiation of seed cells; the freeze-dried extracellular matrixes are convenient to store and prepare and can be used for constructing a tissue engineered intervertebral disc to repair partial defects of the intervertebral disc, and broad clinical application prospects are realized.
Owner:TIANJIN HOSPITAL

Bionic artificial bone and preparation method thereof

The invention relates to a bionic artificial bone. The artificial bone comprises a component A and a component B, wherein the component A is a marine-source biomineralized substance with a natural multiple nano structure, and the component B is an artificial extracellular matrix organic substance. Specifically, the component B in a solution form is a complex of collagen and polysaccharide, and thecomponent A mainly consists of a marine organism exoskeleton of bacillariophyta. The invention also relates to a preparation method of the bionic artificial bone. The bionic artificial bone is bionically compounded of marine-source natural inorganic materials and organic materials, has the natural multiple nano bionic structure, can guide and induce the generation of new tissue, and comprises theinorganic mineralized components of the marine-source natural multiple nano structure and the organic components of an artificial extracellular matrix; the sources are wide, the cost is low, the biological safety is high, and therefore the bionic artificial bone is adopted as a natural bionic extracellular matrix stent material. The prepared bionic artificial bone has high processability and clinical operability and can meet the clinical demands of repairing different bone defects.
Owner:SHANGHAI SIXTH PEOPLES HOSPITAL

Preparation method and application of tissue engineering biological scaffold

The invention relates to a preparation method and application of a tissue engineering biological scaffold, and belongs to the technical field of biological medicines. According to the invention, bioactive glass nanospheres and an acellular cartilage extracellular matrix are included; and the bioactive glass nanospheres and the acellular cartilage extracellular matrix are constructed into the composite scaffold. The composite scaffold not only has the advantages of a decellularized cartilage extracellular matrix scaffold, but also overcomes some defects of a pure decellularized cartilage scaffold, the biological activity of the scaffold is increased, meanwhile, the mechanical property of the scaffold is also increased, and the scaffold can better promote regeneration and repair of cartilage and osteocartilage. By utilizing the characteristics that the acellular cartilage extracellular matrix can be subjected to freeze-drying forming and chemical crosslinking, the defect that bioactive glass nanospheres are not easy to form as granular products is overcome, and the advantages of high specific surface area, solubility, ion slow release characteristic and the like of the bioactive glass nanospheres are fully utilized. The invention provides a good biological scaffold for tissue engineering.
Owner:RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Preparation method of a specific demineralized extracellular matrix scaffold of cross-linked antibiotics

The invention discloses a preparation method of a cross-linked antibiotic specific demineralized extracellular matrix scaffold, and belongs to the technical field of bone infection treatment. The invention discloses a method for preparing a specific demineralized extracellular matrix scaffold of cross-linked antibiotics. The specific demineralized and decellularized cancellous bone extracellular matrix scaffold (SDECM) is used as a substrate, and the specific demineralized and decellularized cancellous bone extracellular matrix scaffold (SDECM) is used as a substrate, and the antibiotic is electrostatically adsorbed and chemically adsorbed. Cross-linking two forms of composite drug loading, releasing antibiotics through rapid pH response and accompanying material degradation in an acidic environment, anti-infection through antibiotics and promoting repair through SDECM, so as to achieve pH-sensitive drug release in an acidic environment in the early stage of infection Rapid sterilization, sustained sterilization by slow release of drugs in the mid-late physiological environment, and permanent sterilization ability to prevent infection recurrence in the absence of infection provide new ideas and tools for the antibacterial and repairing treatment of bone infections.
Owner:杭州源囊生物科技有限公司

Preparation method of gene-activated poly-lactic acid material for treating liver diseases

The invention discloses a gene-activated poly-lactic acid material for treating a liver disease, comprising a poly-lactic acid material body and an activating layer, wherein the activating layer comprises a plasmid DNA layer and a galactose glycosidation chitosan layer, the plasmid DNA layer and the galactose glycosidation chitosan layer are sequentially arranged from the interior to the exterior at intervals, the gene-activated poly-lactic acid material has excellent cellular compatibility, can induce the growth of liver cells in situ, can strengthen the adhesive performance of the liver cells on an extracellular matrix scaffold material, can improve the stability of an implant, further induces the transfer of liver targeted genes, efficiently regulates and controls the genes to release in a targeted manner, strengthens the activity of cells and increases the transfection efficiency so as to realize the treatment of the liver disease. The invention further provides a preparation method of the gene-activated poly-lactic acid material, wherein the galactose glycosidation chitosan layer and the plasmid DNA layer are sequentially deposited on the surface of the poly-lactic acid material by utilizing the electrostatic interaction between the galactose glycosidation chitosan molecules and the plasmid DNAs, the method has simple operation and low cost and is easy to implement and very suitable for the industrial application.
Owner:CHONGQING UNIV

Ovarian extracellular matrix scaffold and hydrogel as well as preparation method and application thereof

The invention discloses an ovarian extracellular matrix scaffold and hydrogel as well as a preparation method and application thereof, and belongs to the technical field of biomedicine and clinical medicine. The preparation method of the ovarian extracellular matrix scaffold comprises the following steps: 1) ovarian tissue pretreatment; 2) multi-decellularization treatment: sequentially putting the ovarian tissue skin and marrow treated in the step 1) into double distilled water, a mixed solution of sodium deoxycholate and triton X-100 and a lauryl sodium sulfate solution, sufficiently shaking and washing, adding DNA enzyme, and culturing in a culture medium at 37 DEG C for 4-8 hours; (3) sterilization and freeze-drying treatment: (4) preparation of the ovarian extracellular matrix scaffold: grinding the freeze-drying tissue prepared in the step (3) into particles with the particle size of less than 1mm, and adding acid liquor, pepsase, alkali liquor and a buffer solution into the particles to prepare the ovarian extracellular matrix scaffold. and continuously adding granular cells and follicles into the ovarian extracellular matrix scaffold to prepare the hydrogel material which can be implanted into a mammal body and has the effects of repairing ovarian injury and reconstructing ovarian functions. The research provides a new strategy for female fertility protection.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products